Nuveen’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Buy |
419,508
+987
| +0.2% | +$23.5K | ﹤0.01% | 1525 |
|
|
2025
Q4 | $9.77M | Sell |
418,521
-123,708
| -23% | -$2.76M | ﹤0.01% | 1561 |
|
|
2025
Q3 | $10.7M | Sell |
542,229
-444,042
| -45% | -$9.13M | ﹤0.01% | 1509 |
|
|
2025
Q2 | $21.4M | Buy |
986,271
+218,259
| +28% | +$5.15M | 0.01% | 1062 |
|
|
2025
Q1 | $17.2M | Sell |
768,012
-536,379
| -41% | -$12.1M | 0.01% | 1216 |
|
|
2024
Q4 | $27.2M | Buy |
1,304,391
+165,249
| +15% | +$3.55M | 0.01% | 979 |
|
|
2024
Q3 | $22.6M | Buy |
1,139,142
+308,586
| +37% | +$5.72M | 0.01% | 1098 |
|
|
2024
Q2 | $12.9M | Buy |
830,556
+260,037
| +46% | +$4.05M | ﹤0.01% | 1422 |
|
|
2024
Q1 | $9.09M | Buy |
570,519
+301,807
| +112% | +$4.55M | ﹤0.01% | 1653 |
|
|
2023
Q4 | $4.52M | Buy |
268,712
+4,877
| +2% | +$66.7K | ﹤0.01% | 2038 |
|
|
2023
Q3 | $3.08M | Buy |
263,835
+4,631
| +2% | +$61.9K | ﹤0.01% | 2112 |
|
|
2023
Q2 | $3.48M | Sell |
259,204
-5,367
| -2% | -$77.2K | ﹤0.01% | 2089 |
|
|
2023
Q1 | $4.39M | Sell |
264,571
-661,306
| -71% | -$10.9M | ﹤0.01% | 1969 |
|
|
2022
Q4 | $17.2M | Sell |
925,877
-457,912
| -33% | -$7.05M | 0.01% | 1150 |
|
|
2022
Q3 | $17.8M | Sell |
1,383,789
-65,968
| -5% | -$782K | 0.01% | 1098 |
|
|
2022
Q2 | $10.2M | Buy |
1,449,757
+751,576
| +108% | +$5.51M | ﹤0.01% | 1498 |
|
|
2022
Q1 | $5.48M | Sell |
698,181
-30,753
| -4% | -$217K | ﹤0.01% | 2013 |
|
|
2021
Q4 | $4.68M | Sell |
728,934
-73,349
| -9% | -$482K | ﹤0.01% | 2163 |
|
|
2021
Q3 | $4.05M | Sell |
802,283
-108,682
| -12% | -$594K | ﹤0.01% | 2326 |
|
|
2021
Q2 | $5.24M | Buy |
910,965
+33,484
| +4% | +$173K | ﹤0.01% | 2221 |
|
|
2021
Q1 | $4.04M | Sell |
877,481
-39,348
| -4% | -$156K | ﹤0.01% | 2266 |
|
|
2020
Q4 | $3.06M | Buy |
916,829
+533,282
| +139% | +$1.79M | ﹤0.01% | 2295 |
|
|
2020
Q3 | $1.14M | Buy |
383,547
+1,910
| +0.5% | +$7.47K | ﹤0.01% | 2631 |
|
|
2020
Q2 | $1.76M | Sell |
381,637
-17,781
| -4% | -$79.9K | ﹤0.01% | 2392 |
|
|
2020
Q1 | $1.54M | Sell |
399,418
-1,750,115
| -81% | -$7.18M | ﹤0.01% | 2316 |
|
|
2019
Q4 | $8.06M | Buy |
2,149,533
+1,748,591
| +436% | +$8.18M | ﹤0.01% | 1720 |
|
|
2019
Q3 | $2.13M | Buy |
400,942
+6,377
| +2% | +$34K | ﹤0.01% | 2368 |
|
|
2019
Q2 | $1.51M | Buy |
+394,565
| New | +$1.7M | ﹤0.01% | 2563 |
|
Other funds holding CPRX
VCM
DM
VPM